Thorne HealthTech Performance
| THRNDelisted Stock | USD 6.40 0.48 8.11% |
The entity has a beta of 0.58, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Thorne HealthTech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Thorne HealthTech is expected to be smaller as well. Thorne HealthTech right now has a risk of 0.0%. Please validate Thorne HealthTech skewness, and the relationship between the value at risk and day median price , to decide if Thorne HealthTech will be following its existing price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Thorne HealthTech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Thorne HealthTech is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 56 M |
Thorne |
Thorne HealthTech Relative Risk vs. Return Landscape
If you would invest 640.00 in Thorne HealthTech on August 30, 2024 and sell it today you would earn a total of 0.00 from holding Thorne HealthTech or generate 0.0% return on investment over 90 days. Thorne HealthTech is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Thorne, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Thorne HealthTech Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Thorne HealthTech's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Thorne HealthTech, and traders can use it to determine the average amount a Thorne HealthTech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| THRN |
Based on monthly moving average Thorne HealthTech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Thorne HealthTech by adding Thorne HealthTech to a well-diversified portfolio.
Thorne HealthTech Fundamentals Growth
Thorne Stock prices reflect investors' perceptions of the future prospects and financial health of Thorne HealthTech, and Thorne HealthTech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Thorne Stock performance.
| Price To Earning | 100.20 X | |||
| Revenue | 228.73 M | |||
| EBITDA | 10.31 M | |||
| Cash And Equivalents | 27.81 M | |||
| Cash Per Share | 0.53 X | |||
| Total Debt | 47.03 M | |||
| Debt To Equity | 0.24 % | |||
| Book Value Per Share | 2.46 X | |||
| Cash Flow From Operations | 5.22 M | |||
| Earnings Per Share | 0.15 X | |||
| Total Asset | 229.8 M | |||
| Retained Earnings | (116.48 M) | |||
About Thorne HealthTech Performance
By examining Thorne HealthTech's fundamental ratios, stakeholders can obtain critical insights into Thorne HealthTech's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Thorne HealthTech is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York. Thorne Healthtech operates under Packaged Foods classification in the United States and is traded on NASDAQ Exchange. It employs 496 people.Things to note about Thorne HealthTech performance evaluation
Checking the ongoing alerts about Thorne HealthTech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Thorne HealthTech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Thorne HealthTech is not yet fully synchronised with the market data | |
| Thorne HealthTech has a very high chance of going through financial distress in the upcoming years |
- Analyzing Thorne HealthTech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Thorne HealthTech's stock is overvalued or undervalued compared to its peers.
- Examining Thorne HealthTech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Thorne HealthTech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Thorne HealthTech's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Thorne HealthTech's stock. These opinions can provide insight into Thorne HealthTech's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Thorne Stock
If you are still planning to invest in Thorne HealthTech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Thorne HealthTech's history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |